Brazil probes three
deaths with Zika links, aims for vaccine in a year
Send a link to a friend
[February 12, 2016]
By Maria Carolina Marcello
BRASILIA (Reuters) - Recent laboratory
analyses identified Zika virus infections in three people who died in
Brazil last year, the health ministry said on Thursday, although
authorities could not confirm that Zika alone was responsible for their
deaths.
|
Brazilian Health Minister Marcelo Castro confirmed the findings at a
press conference, while announcing that a new partnership with
scientists at the University of Texas could lead to laboratory
development of a vaccine within a year. He cautioned that
full-fledged availability of a vaccine against the mosquito-borne
virus would take longer.
The developments are the latest in an ongoing struggle with Zika in
Brazil, which is at the center of an outbreak that has spread to
more than 30 countries and has prompted the World Health
Organization to declare a global emergency over possible links
between the virus and birth defects.
The ministry said Brazilian researchers found the virus in the body
of a 20-year-old woman in the northeastern state of Rio Grande do
Norte, who died last April from respiratory problems. Two other
patients last year also died from complications while they were
infected with the virus.
Castro said the deaths possibly illustrated "comorbidity" caused by
the virus and complications it may have caused in the patients. The
woman's respiratory problems were likely "associated with the
infection," he said.
Only one in five people infected with Zika experience illness and
even then they are normally mild symptoms. The virus is still poorly
understood by scientists.
The government believes that as many as 1.5 million Brazilians may
have been infected by Zika so far. Scientists are investigating a
potential link between infections of pregnant women and more than
4,000 suspected cases in Brazil of microcephaly, a condition marked
by abnormally small head size that can result in developmental
problems.
Though laboratory tests have showed traces of Zika in patients
affected by the believed complications, no proof yet exists to show
it causes the birth deformations or any reported deaths.
VACCINE EFFORTS
Researchers in Brazil and elsewhere are pushing ahead with efforts
to better diagnose and prevent Zika infections.
[to top of second column] |
Castro and Pedro Vasconcelos, a doctor at the Evandro Chagas
Institute of Infectious Diseases, announced the vaccine partnership
with the U.S. researchers as Brazil pledged $1.9 million to the
effort over the next five years.
Castro said development of a vaccine could come as quickly as within
one year, but said that another two years would likely be needed for
any large-scale rollout of a successful vaccine.
The timeline is similar to that suggested by researchers elsewhere,
many of whom say clinical availability of any Zika vaccine is still
at least three years away. Researchers note that a vaccine for
dengue, a similar virus that so far affects many more people than
Zika, is still not widely available, despite successful models.
Castro said the ministry hopes to distribute tests soon that could
be used to speed up diagnoses of patients with active symptoms of
Zika, dengue and Chikungunya, another related viral infection.
At present, doctors have relied mostly on costly genetic tests to
find traces of the virus in some patients, but those tests, known as
PCR, are not widely available and are limited to when a patient is
actively showing symptoms.
Though the new test is also limited to when patients have symptoms
of the illnesses, it can be used at more facilities and could
provide some diagnoses in a matter of hours, the ministry said.
(Reporting by Silvio Cascione and Maria Carolina Marcello; Writing
by Paulo Prada; Editing by Frances Kerry)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|